Skip to main content

Table 1 Performance characteristics of Genotype MTBDRplus VER 2.0 LPA for detection RMP and INH resistance and MDR-TB in smear positive direct sample, 2015

From: Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples

Detection of drug resistance

MGIT R

MGIT S

LPA R

LPA S

Sensitivity%

Specificity%

PPV%

NPV%

(95%* CI)

(95%* CI)

(95%* CI)

(95%* CI)

*RMP

34

38

34

38

88.2 (72.6–96.7)

89.5 (75.2–97.1)

88.2 (72.6–96.7)

89.5 (75.2–97.1)

*INH

36

36

34

38

91.7 (77.5–98.3)

97.2 (85.5–99.9)

97.1 (84.7–99.9)

92.1 (78.6–98.3)

*MDR-TB (RMP&INH)

28

31

27

32

96.4 (81.7–99.9)

100 (88.8–100)

100 (87.2–100)

96.9 (83.8–99.9)

  1. *RMP Rifampicin, INH Isoniazid, MDR-TB Multidrug resistant Tuberculosis, R Resistant, S Susceptible, CI Confidence Interval